Correlation Between Agios Pharm and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Agios Pharm and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Agios Pharm and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Mineralys Therapeutics,.

Diversification Opportunities for Agios Pharm and Mineralys Therapeutics,

-0.53

Correlation Coefficient

Agios Pharm  Mineralys Therapeutics,

Excellent diversification

The 3 months correlation between Agios and Mineralys is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Agios Pharm i.e., Agios Pharm and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between Agios Pharm and Mineralys Therapeutics,

Given the investment horizon of 90 days Agios Pharm is expected to generate 0.84 times more return on investment than Mineralys Therapeutics,. However, Agios Pharm is 1.19 times less risky than Mineralys Therapeutics,. It trades about 0.11 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.05 per unit of risk. If you would invest  2,997  in Agios Pharm on May 5, 2025 and sell it today you would earn a total of  503.00  from holding Agios Pharm or generate 16.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Agios Pharm  vs.  Mineralys Therapeutics, Common

Agios Pharm

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Agios Pharm and Mineralys Therapeutics,

The main advantage of trading using opposite Agios Pharm and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind Agios Pharm and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.